Target intelligence / Profile preview

Novel transcript, antisense to PAK1 (ENSG00000268635)

Target
ENSG00000268635
Molecular classification
Long noncoding RNA (lncRNA), Natural antisense transcript (NAT)
01

Overview

Novel transcript, antisense to PAK1 (ENSG00000268635) is a long noncoding RNA classified as a natural antisense transcript (NAT) that overlaps the PAK1 gene. NATs are widespread regulators in the genome, frequently exerting transcriptional and post-transcriptional control over their sense gene counterparts. Mechanisms include transcriptional interference (hindering sense gene expression by promoter competition or RNA polymerase collision), RNA masking (duplex formation that regulates splicing, stability, or translation), activation of RNA interference pathways (via double-stranded RNA formation), and epigenetic modification (such as inducing histone or DNA methylation). While antisense regulation of protein-coding genes like PAK1 can contribute to various biological outcomes—including cell proliferation, apoptosis, and gene silencing—the specific function and disease association for ENSG00000268635 remain uncharacterized in the literature. It is not regarded as a druggable molecular target, nor are there known drugs, biomarkers, or safety issues documented for this RNA gene[1][2][3][4][5].

Other names
GC11P07747Novel transcript, antisense to PAK1
02

Biological functions

Negative regulation of sense gene expression (such as PAK1)Chromatin remodelingTranscriptional interferenceRNA maskingdsRNA-dependent RNA interferenceEpigenetic modification (e.g., DNA/histone methylation)
03

Disease associations

Other

Beyond the preview

Go deeper on Novel transcript, antisense to PAK1 (ENSG00000268635).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to PAK1 (ENSG00000268635).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call